BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34705066)

  • 1. Use of acid-suppressive drugs and risk of fracture in children and young adults: a meta-analysis of observational studies.
    Yang J; Zhou TJ; Yang J; Bao DN
    Eur J Clin Pharmacol; 2022 Mar; 78(3):365-373. PubMed ID: 34705066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
    Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
    Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies.
    Eom CS; Park SM; Myung SK; Yun JM; Ahn JS
    Ann Fam Med; 2011; 9(3):257-67. PubMed ID: 21555754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acid-Suppressive Drugs and Risk of Fracture in Children and Young Adults: A Meta-Analysis of Observational Studies.
    Li J; Xie X; Liu W; Gu F; Zhang K; Su Z; Wen Q; Sui Z; Zhou P; Yu T
    Front Pharmacol; 2021; 12():712939. PubMed ID: 34421609
    [No Abstract]   [Full Text] [Related]  

  • 5. Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies.
    Yu EW; Bauer SR; Bain PA; Bauer DC
    Am J Med; 2011 Jun; 124(6):519-26. PubMed ID: 21605729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: risk of fractures with acid-suppressing medication.
    Kwok CS; Yeong JK; Loke YK
    Bone; 2011 Apr; 48(4):768-76. PubMed ID: 21185417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Acid Suppression Therapy Exposure and Fracture in Young Children.
    Malchodi L; Wagner K; Susi A; Gorman G; Hisle-Gorman E
    Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31175146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.
    Wijarnpreecha K; Thongprayoon C; Chesdachai S; Panjawatanana P; Ungprasert P; Cheungpasitporn W
    Dig Dis Sci; 2017 Oct; 62(10):2821-2827. PubMed ID: 28836158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acid-suppressive medications and risk of bone loss and fracture in older adults.
    Yu EW; Blackwell T; Ensrud KE; Hillier TA; Lane NE; Orwoll E; Bauer DC
    Calcif Tissue Int; 2008 Oct; 83(4):251-9. PubMed ID: 18813868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
    Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
    Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
    Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
    Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
    Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
    Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting.
    Cea Soriano L; Ruigómez A; Johansson S; García Rodríguez LA
    Pharmacotherapy; 2014 Jun; 34(6):570-81. PubMed ID: 24634193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
    Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton-pump inhibitors and risk of fractures: an update meta-analysis.
    Zhou B; Huang Y; Li H; Sun W; Liu J
    Osteoporos Int; 2016 Jan; 27(1):339-47. PubMed ID: 26462494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
    Fedida B; Schermann H; Ankory R; Rotman D; Shichman I; Yoffe V; Shlaifer A; Luger E
    Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing safety of proton-pump inhibitors versus H2-receptor antagonists in kidney transplant recipients: A systematic review and meta-analysis.
    Mohammadi K; Yaribash S; Razi B; Dashti-Khavidaki S
    J Clin Pharm Ther; 2022 May; 47(5):567-574. PubMed ID: 34931328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter cohort analysis of fractures in histamine-2-receptor antagonist treated pediatric patients.
    Fleishman NR; Richardson T; Attard TM
    Curr Med Res Opin; 2022 Apr; 38(4):565-570. PubMed ID: 35112645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid-suppressive medications and risk of pneumonia in acute stroke patients: A systematic review and meta-analysis.
    Marchina S; Doros G; Modak J; Helenius J; Aycock DM; Kumar S
    J Neurol Sci; 2019 May; 400():122-128. PubMed ID: 30927619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No association between acid suppressant use and risk of dementia: an updated meta-analysis.
    Wang H; Tian L; Yan X
    Eur J Clin Pharmacol; 2022 Mar; 78(3):375-382. PubMed ID: 34811582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.